ERBB2 and neoplasm: A previous study on xenograft models investigating CAR-T cell therapy targeting HER2 on gastric cancer cells showed improved tumor inhibition and long-term survival, suggesting a need for clinical trials investigating the potential role of CAR-T cell therapy in HER-positive gastric cancer patients [73].